ACADIA Pharmaceuticals Financial Market Data
| Last Close 14-Aug-2008 |
$3.21 |
Price/ Sales Ratio |
25.28 |
| 52-Week High |
$16.56 |
Price/ Book Ratio |
1.41 |
| 52-Week Low |
$2.32 |
Price/ Earnings Ratio |
-- |
| 60-Month Beta |
2.2 |
Price/ Cash Flow Ratio |
-- |
| Market Cap (mil.) |
$119.2 |
Return on Assets |
(52.9%) |
| Shares Outstanding (mil.) |
37.1 |
Return on Equity |
(60.1%) |
| Dividend Rate |
-- |
Current Ratio |
6.70 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
0.02 |
| # of Institutional Holders |
75 |
% Owned by Institutions |
81.0% |
| Latest Short Interest Ratio |
13.07 |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
(41.5%) |
(39.7%) |
0.0% |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
